Risk and Outcome of Breakthrough COVID-19 Infections in Vaccinated Patients With Cancer: Real-World Evidence From the National COVID Cohort Collaborative

PURPOSE: To provide real-world evidence on risks and outcomes of breakthrough COVID-19 infections in vaccinated patients with cancer using the largest national cohort of COVID-19 cases and controls. METHODS: We used the National COVID Cohort Collaborative (N3C) to identify breakthrough infections be...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Qianqian, Bates, Benjamin, Shao, Yu Raymond, Hsu, Fang-Chi, Liu, Feifan, Madhira, Vithal, Mitra, Amit Kumar, Bergquist, Timothy, Kavuluru, Ramakanth, Li, Xiaochun, Sharafeldin, Noha, Su, Jing, Topaloglu, Umit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061155/
https://www.ncbi.nlm.nih.gov/pubmed/35286152
http://dx.doi.org/10.1200/JCO.21.02419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061155/
https://www.ncbi.nlm.nih.gov/pubmed/35286152
http://dx.doi.org/10.1200/JCO.21.02419

Ejemplares similares